OCP CONNECT helps laboratories ensure the success of their pharmacy strategies
Strategy – Consulting – Action
A unique approach to help you achieve your objectives.
Discover our events, our forthcoming meetings, our latest innovations.
Sharing our experience and our expertise to help you determine your strategic orientations.
The OCP CONNECT team is always available to find answers to your challenges
Stimulating sales, new brand implementation, point of sales presence and visibility for your products …
Targeting, telesales, Com’en sac...OCP CONNECT provides you with the most appropriate solution.
Mobilise a complementary target, back up the launch of an OTC product, help with advising lumbago sufferers...,…
3 Chênes
AIM
Abbott Diabetes Care
Argiletz
Asepta
BD
Boehringer Ingelheim
Bouchara Recordati
Ciba Vision
…
The OCP CONNECT team is always available to find answers to your challenges
Product risk management plans, compliance, home-based management of side effects, therapeutic education…
The pharmacist is a frontline actor in patient support.
Targeting, e-detailing, “Spot Santé”…OCP CONNECT creates and implements innovative solutions
Support pharmacies in the delivery of an anti-cancer drug, promoting appropriate useof a new treatment…
Abbott
Amgen
Aguettant
...
The OCP CONNECT team is always available to find answers to your challenges
Making stock on a new generic available on Day One, launch of a biosimilar, maintaining market share…
Targeting, distance sales, public display,.. OCP CONNECT: your partner with the most appropriate solution,
Ensuring delivery in the 24 hours following Day One, creating synergies between GPs and pharmacists ones actions
Actavis
Biogaran
Insights Agents
Mylan
Ratiopharm
Sandoz
Teva
The OCP CONNECT team is always available to find answers to your challenges
The repertoire of generic groups represents 1/3 of the volume of the pharmacy market in 2010 increasing by +15% (source: GERS 2011). In 2010, the substitution rate was stable at 79%.
The pharmacist - pillar of generics policy in France:
Three quarters of French patients buy generics, and in more than 50% of cases the pharmacist suggests the substitution.
In 2010, a new agreement was adopted by pharmacists’ associations and national health insurance fixing a national objective of 80% substitution rate for generic molecules in 18 months. This agreement withdraws third-party payment for all subscribers who refuse to accept a generic medicine when prescribed by the GP or suggested by the pharmacist.
- Offering stock on generic available the same day as the expiration of the patent
- Limitations to substitution in treatments for severe pathologies and niche products
- Launching a biosimilar
- Maintaining market share during range extension
- Catalogue exploitation
- Launching an exclusive or semi-exclusive generic
- Relaying a mass media campaign in pharmacies
- Establishing positioning as a health actor
Your opinion interests us
